Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma.

Blaes J, Thomé CM, Pfenning PN, Rübmann P, Sahm F, Wick A, Bunse T, Schmenger T, Sykora J, von Deimling A, Wiestler B, Merz C, Jugold M, Haberkorn U, Abdollahi A, Debus J, Gieffers C, Kunz C, Bendszus M, Kluge M, Platten M, Fricke H, Wick W, Lemke D.

Mol Cancer Res. 2018 May;16(5):767-776. doi: 10.1158/1541-7786.MCR-17-0563. Epub 2018 Feb 16.

PMID:
29453321
2.

Tweety-Homolog 1 Drives Brain Colonization of Gliomas.

Jung E, Osswald M, Blaes J, Wiestler B, Sahm F, Schmenger T, Solecki G, Deumelandt K, Kurz FT, Xie R, Weil S, Heil O, Thomé C, Gömmel M, Syed M, Häring P, Huber PE, Heiland S, Platten M, von Deimling A, Wick W, Winkler F.

J Neurosci. 2017 Jul 19;37(29):6837-6850. doi: 10.1523/JNEUROSCI.3532-16.2017. Epub 2017 Jun 12.

3.

Prognostic relevance of miRNA-155 methylation in anaplastic glioma.

Schliesser MG, Claus R, Hielscher T, Grimm C, Weichenhan D, Blaes J, Wiestler B, Hau P, Schramm J, Sahm F, Weiß EK, Weiler M, Baer C, Schmidt-Graf F, Schackert G, Westphal M, Hertenstein A, Roth P, Galldiks N, Hartmann C, Pietsch T, Felsberg J, Reifenberger G, Sabel MC, Winkler F, von Deimling A, Meisner C, Vajkoczy P, Platten M, Weller M, Plass C, Wick W.

Oncotarget. 2016 Dec 13;7(50):82028-82045. doi: 10.18632/oncotarget.13452.

4.

Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases.

Osswald M, Blaes J, Liao Y, Solecki G, Gömmel M, Berghoff AS, Salphati L, Wallin JJ, Phillips HS, Wick W, Winkler F.

Clin Cancer Res. 2016 Dec 15;22(24):6078-6087. Epub 2016 Aug 12.

5.

Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy.

Lemke D, Pledl HW, Zorn M, Jugold M, Green E, Blaes J, Löw S, Hertenstein A, Ott M, Sahm F, Steffen AC, Weiler M, Winkler F, Platten M, Dong Z, Wick W.

Oncotarget. 2016 Aug 30;7(35):56713-56725. doi: 10.18632/oncotarget.10723.

6.

Brain tumour cells interconnect to a functional and resistant network.

Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J, Weil S, Horstmann H, Wiestler B, Syed M, Huang L, Ratliff M, Karimian Jazi K, Kurz FT, Schmenger T, Lemke D, Gömmel M, Pauli M, Liao Y, Häring P, Pusch S, Herl V, Steinhäuser C, Krunic D, Jarahian M, Miletic H, Berghoff AS, Griesbeck O, Kalamakis G, Garaschuk O, Preusser M, Weiss S, Liu H, Heiland S, Platten M, Huber PE, Kuner T, von Deimling A, Wick W, Winkler F.

Nature. 2015 Dec 3;528(7580):93-8. doi: 10.1038/nature16071. Epub 2015 Nov 4.

PMID:
26536111
7.

NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.

Broggini T, Wüstner M, Harms C, Stange L, Blaes J, Thomé C, Harms U, Mueller S, Weiler M, Wick W, Vajkoczy P, Czabanka M.

Cancer Lett. 2016 Oct 1;380(2):568-76. doi: 10.1016/j.canlet.2015.06.026. Epub 2015 Aug 20.

PMID:
26297987
8.

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.

Kessler T, Sahm F, Blaes J, Osswald M, Rübmann P, Milford D, Urban S, Jestaedt L, Heiland S, Bendszus M, Hertenstein A, Pfenning PN, Ruiz de Almodóvar C, Wick A, Winkler F, von Deimling A, Platten M, Wick W, Weiler M.

Oncotarget. 2015 Oct 13;6(31):31050-68. doi: 10.18632/oncotarget.2910.

9.

Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.

Ott M, Litzenburger UM, Rauschenbach KJ, Bunse L, Ochs K, Sahm F, Pusch S, Opitz CA, Blaes J, von Deimling A, Wick W, Platten M.

Glia. 2015 Jan;63(1):78-90. doi: 10.1002/glia.22734. Epub 2014 Aug 5.

PMID:
25132599
10.

Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?

Lemke D, Weiler M, Blaes J, Wiestler B, Jestaedt L, Klein AC, Löw S, Eisele G, Radlwimmer B, Capper D, Schmieder K, Mittelbronn M, Combs SE, Bendszus M, Weller M, Platten M, Wick W.

J Neurochem. 2014 Oct;131(2):251-64. doi: 10.1111/jnc.12802. Epub 2014 Jul 18.

11.

Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival.

Zhu Z, Khan MA, Weiler M, Blaes J, Jestaedt L, Geibert M, Zou P, Gronych J, Bernhardt O, Korshunov A, Bugner V, Lichter P, Radlwimmer B, Heiland S, Bendszus M, Wick W, Liu HK.

Cell Stem Cell. 2014 Aug 7;15(2):185-98. doi: 10.1016/j.stem.2014.04.007. Epub 2014 May 15.

12.

NDRG1 prognosticates the natural course of disease in WHO grade II glioma.

Blaes J, Weiler M, Sahm F, Hentschel B, Osswald M, Czabanka M, Thomé CM, Schliesser MG, Pusch S, Luger S, Winkler F, Radbruch A, Jugold M, Simon M, Steinbach JP, Schackert G, Tatagiba M, Westphal M, Tonn JC, Gramatzki D, Pietsch T, Hartmann C, Glimm H, Vajkoczy P, von Deimling A, Platten M, Weller M, Wick W.

J Neurooncol. 2014 Mar;117(1):25-32. doi: 10.1007/s11060-013-1357-2. Epub 2014 Jan 7.

13.

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.

Weiler M, Blaes J, Pusch S, Sahm F, Czabanka M, Luger S, Bunse L, Solecki G, Eichwald V, Jugold M, Hodecker S, Osswald M, Meisner C, Hielscher T, Rübmann P, Pfenning PN, Ronellenfitsch M, Kempf T, Schnölzer M, Abdollahi A, Lang F, Bendszus M, von Deimling A, Winkler F, Weller M, Vajkoczy P, Platten M, Wick W.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):409-14. doi: 10.1073/pnas.1314469111. Epub 2013 Dec 23.

14.

mTORC 2:1 for chemotherapy sensitization in glioblastoma.

Wick W, Blaes J, Weiler M.

Cancer Discov. 2011 Nov;1(6):475-6. doi: 10.1158/2159-8290.CD-11-0264.

15.

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

Weiler M, Pfenning PN, Thiepold AL, Blaes J, Jestaedt L, Gronych J, Dittmann LM, Berger B, Jugold M, Kosch M, Combs SE, von Deimling A, Weller M, Bendszus M, Platten M, Wick W.

Oncogene. 2013 Feb 28;32(9):1099-109. doi: 10.1038/onc.2012.137. Epub 2012 May 7.

16.

A tempest in a teapot.

Blaes J.

Dent Assist. 2006 Nov-Dec;75(6):4. No abstract available.

PMID:
17191650
17.

Making esthetic provisionals.

Blaes JA.

N Y State Dent J. 2004 Apr;70(4):24-7.

PMID:
15270310
18.

Today's technology improves the shade-matching problems of yesterday.

Blaes J.

J Indiana Dent Assoc. 2002-2003 Winter;81(4):17-9. No abstract available.

PMID:
12593181
19.

Commit to being the best.

Blaes JA.

Dent Assist. 2000 Mar-Apr;69(2):3-4. No abstract available.

PMID:
11218291
20.

Dental economics: a non-subscription dental journal.

Blaes JA.

J Am Coll Dent. 1999 Winter;66(4):29-30.

PMID:
10665238
21.

Cosmetic dentistry 99.

Blaes JA.

Dent Econ. 1998 Dec;88(12):17-8. No abstract available.

PMID:
10379240
22.

The survival of fee-for-service dentistry.

Blaes JA.

Dent Econ. 1999 Jan;89(1):17-8. No abstract available.

PMID:
10356439
23.

From afar. 'Distance learning' closes the information gap by delivering it right into the practice.

Blaes JA.

Dent Econ. 1998 Apr;88(4):68-70. No abstract available.

PMID:
10200677
24.

The learning of business.

Blaes J.

Dent Econ. 1998 Jun;88(6):10. No abstract available.

PMID:
10200653
25.

How to profit from practice survey. The inside scoop on Dr. Typical.

Blaes JA, Blair C.

Dent Econ. 1998 May;88(5):30-3. No abstract available.

PMID:
10200642
26.

Dentistry joins a global pursuit for quality.

Blaes J.

Dent Econ. 1997 Oct;87(10):46-8. No abstract available.

PMID:
9534393
27.

How to profit from .... practice analysis. Survey examines trends in collections.

Blaes J.

Dent Econ. 1997 Oct;87(10):28-30, 91. No abstract available.

PMID:
9534390
28.

Why lower fees mean more work.

Blaes J.

Dent Econ. 1997 May;87(5):22. No abstract available.

PMID:
9452559
29.

Let's stop the waiting game: no more single crowns!

Blaes JA.

Dent Econ. 1997 Feb;87(2):28-9. No abstract available.

PMID:
9452550
30.

Ten pearls that can increase profitability and productivity.

Blaes JA.

Dent Econ. 1994 Jul;84(7):61-2. No abstract available.

PMID:
7995438
31.

Group compensation: dividing the pie.

Blaes JA.

J Tenn Dent Assoc. 1979 Jan;59(1):27-9. No abstract available.

PMID:
296304

Supplemental Content

Support Center